ZWJ Investment Counsel’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,773
Closed -$375K 205
2019
Q4
$375K Buy
+5,773
New +$376K 0.03% 169
2019
Q3
Sell
-3,947
Closed -$267K 155
2019
Q2
$267K Sell
3,947
-450
-10% -$29.6K 0.02% 139
2019
Q1
$286K Sell
4,397
-1,583
-26% -$105K 0.02% 131
2018
Q4
$374K Sell
5,980
-228
-4% -$15.9K 0.04% 119
2018
Q3
$479K Buy
6,208
+35
+0.6% +$2.64K 0.04% 113
2018
Q2
$437K Sell
6,173
-222,292
-97% -$15.7M 0.04% 112
2018
Q1
$17.2M Sell
228,465
-17,266
-7% -$1.37M 1.55% 28
2017
Q4
$17.6M Sell
245,731
-17,264
-7% -$1.31M 1.39% 28
2017
Q3
$21.3M Sell
262,995
-55,710
-17% -$4.26M 1.66% 25
2017
Q2
$22.6M Sell
318,705
-3,990
-1% -$266K 1.8% 18
2017
Q1
$21.9M Buy
322,695
+105,704
+49% +$7.43M 1.8% 18
2016
Q4
$15.5M Sell
216,991
-18,731
-8% -$1.39M 1.49% 27
2016
Q3
$18.7M Buy
235,722
+11,368
+5% +$923K 1.86% 17
2016
Q2
$18.7M Buy
224,354
+3,977
+2% +$353K 1.87% 20
2016
Q1
$20.2M Buy
220,377
+3,857
+2% +$348K 2.14% 14
2015
Q4
$21.9M Sell
216,520
-342
-0.2% -$35.6K 2.39% 6
2015
Q3
$21.3M Buy
216,862
+872
+0.4% +$96.8K 2.42% 6
2015
Q2
$25.3M Sell
215,990
-9,058
-4% -$990K 2.63% 3
2015
Q1
$22.1M Buy
225,048
+15,530
+7% +$1.58M 2.31% 6
2014
Q4
$19.7M Buy
209,518
+4,044
+2% +$418K 2% 9
2014
Q3
$21.9M Sell
205,474
-51,454
-20% -$5.04M 2.35% 4
2014
Q2
$21.3M Sell
256,928
-4,417
-2% -$344K 2.38% 4
2014
Q1
$18.5M Sell
261,345
-52,026
-17% -$4.08M 2.14% 8
2013
Q4
$23.5M Buy
313,371
+705
+0.2% +$49.1K 2.71% 3
2013
Q3
$19.7M Buy
312,666
+3,651
+1% +$218K 2.52% 4
2013
Q2
$15.8M Buy
+309,015
New +$16.1M 2.14% 7

Other funds holding GILD

ZWJ Investment Counsel's GILD Position: Q1 2020 in Review

ZWJ Investment Counsel sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 5,773 shares — an estimated $375K sold.

ZWJ Investment Counsel first reported a position in GILD in Q2 2013 and held it in 26 quarters. The position peaked at $25.3M in Q2 2015. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • ZWJ Investment Counsel reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • ZWJ Investment Counsel sold 5,773 Gilead Sciences shares in Q1 2020, an estimated $375K.
  • ZWJ Investment Counsel first reported a position in Gilead Sciences in Q2 2013 and held it in 26 quarters.
  • ZWJ Investment Counsel's Gilead Sciences position peaked at $25.3M in Q2 2015.
  • 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on ZWJ Investment Counsel's 13F filing for Q1 2020, filed 18 May 2020.